📰 Granted News
Page 109 - Granted News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Granted. Real-time updates on events, politics, business and more.
April 27, 2022
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the European Commission (EC) has granted marketing authorization for VYDURA (rimegepant), a
April 27, 2022
UPPSALA, Sweden, April 27, 2022 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces today that the company's partner Gesynta Pharma AB which owns all the rights to OX-MPI (GS248)
April 23, 2022
Jharkhand High Court on Friday granted Rashtriya Janata Dal (RJD) chief Lalu Prasad bail in the Rs 139.35-crore illegal withdrawal from Doranda Treasury. The ca
April 21, 2022
25th patent grant is Lexaria's first-ever patent for the enhanced delivery of antiviralsKELOWNA, BC / ACCESSWIRE / April 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company"
April 20, 2022
CHENGDU, China, April 20, 2022 /PRNewswire/ -- Keymed Biosciences (2162.HK) announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for
April 19, 2022
LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L) and Daiichi Sankyo said that they have received notification of acceptance of the supplemental Biologics License Application of ENHERTU (fam-trastuzumab
April 19, 2022
The chief judge of the U.S. District Court for the District of Montana invalidated Trump-era oil and gas lease sales, citing a failure to comply with Obama-era regulations for the greater sage grouse. The decision applies to leases in Nevada and Wyoming and follows that judge’s earlier cancellation of Trump-era oil and gas lease sales| USSA News
April 19, 2022
ENGLEWOOD, CO / ACCESSWIRE / April 19, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the U.S. Food
April 14, 2022
New submission date for Day 120 responses: October 2022 Restart of validation batches in Q3 2022 Committee for Medicinal Products for Human Use (CHMP) opinion expected by Q3 2023 Regulatory